Management Tracks: Agios’ Biller to retire as CSO; plus Vectura, Molecular Partners, F-star and more

Agios Pharmaceuticals Inc. (NASDAQ:AGIO) said CSO Scott Biller will retire at year end. The cellular metabolism company is searching for a successor.

Vectura Group plc (LSE:VEC) said CFO Paul Fry will

Read the full 313 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE